A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
PHASE1
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma
PHASE4
The main aim is to show that long-term use of ixazomib can improve symptoms...
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
PHASE3
A study designed tocompare progression-free survival (PFS) in participants ...
Status
Active Not Recruiting
Location
Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407